Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish

Human Immunology

Volumn 65, Issue 4, 2004, Pages 340-346

  Ross, Owen A ^a,b   O'Neill, Claire ^a,b   Rea, I Maeve ^a   Lynch, Tim ^e,f   Gosal, David ^e,f   Wallace, Andrew ^a   Curran, Martin D ^a,b   Middleton, Derek ^a,b,d   Gibson, J Mark ^c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ULSTER   (United Kingdom)

^e MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

interleukin 8; Parkinson's disease; polymorphism; proinflammatory

Indexed keywords

CHEMOKINE; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGING; ARTICLE; BRAIN; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENCEPHALITIS; FEMALE; GENE ACTIVITY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; FEMALE; HUMANS; INTERLEUKIN-8; IRELAND; MALE; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 2142849942     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.01.015     Document Type: Article

References (32)

1. McGreer P.L., McGreer E.G. The role of the immune system in neurodegenerative disorders. Mov Disord. 12:1997;855
2. Allan S.M., Rothwell N.J. Cytokines and acute degeneration. Nat Rev Neurosci. 2:2001;734
3. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 180:1994;147
4. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett. 211:1996;13
5. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Rieder P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett. 202:1995;17
6. Dobbs R.J., Charlett A., Purkiss A.G., Dobbs S.M., Weller C., Peterson D.W. Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand. 100:1999;34
7. Czlonkowska A., Kurkowska-Jastrzebska I., Czlonkowski A., Peter D., Stefano G.B. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide. Med Sci Monit. 8:2002;RA165
8. Kruger R., Hardt C., Tschentscher F., Jackel S., Kuhn W., Muller T., Werner J., Woitalla D., Berg D., Kuhnl N., Fuchs G.A., Santos E.J. M, Przuntek H, Epplen JT, Schols L, Riess O Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm. 107:2000;553
9. Nishimura M., Mizute I., Mizuta E., Yamasaki S., Ohta M., Kuno S. Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease. Neurosci Lett. 284:2000;73
10. Nishimura M., Mizute I., Mizuta E., Yamasaki S., Ohta M., Kuno S. Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease. Neurosci Lett. 311:2001;1
11. McGreer P.L., Yasojima K., McGreer E.G. Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease. Neurosci Lett. 326:2002;67
12. Schulte T., Schols L., Muller T., Woitalla D., Berger K., Kruger R. Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci Lett. 326:2002;70
13. Rea I.M., McMaster D., Woodside J.V., Young I.S., Archbold G.P., Linton T., Lennox S., McNulty H., Harmon D.L., Whitehead A.S. Community-living nonagenarians in Northern Ireland have lower plasma homocysteine but similar methylenetetrahydrofolate reductase thermolabile genotype prevalence compared to 70-89-year-old subjects. Atherosclerosis. 149:2000;207
14. Ligthart GJ, Corberand JX, Goertzen HG: M, Minders AE, Knook DL, Hijmans W: Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Age Dev 55:89, 1990
15. Middleton D., Williams F., Cullen C., Mallon E. Modification of an HLA-B PCR-SSOP typing system leading to improved allele determination. Tissue Antigens. 45:1995;232
16. Williams F., Meenagh A., Maxwell A.P., Middleton D. Allele resolution of HLA-A using oligonucleotide probes in a two stage typing strategy. Tissue Antigens. 54:1999;59
17. Meenagh A., Williams F., Ross O.A., Patterson C., Gorodezky C., Hammond M., Leheny W.A., Middleton D. Frequency of cytokine polymorphisms in populations from Western Europe, Africa, Asia, the Middle East and South America. Hum Immunol. 63:2002;1055
18. Franceschi C., Valensin F., Olivieri F., Licastro F., Grimaldi L.M.E., Monti D., De Benedictis G., Bonafe M. Neuroinflammation and the genetics of Alzheimer's disease the search for a pro-inflammatory phenotype. Aging Clin Exp Res. 13:2001;163
19. McCusker S.M., Curran M.D., Dynan K.B., McCullagh C.D., Urquhart D.D., Middleton D., Patterson C.C., McIlroy S.P., Passmore A.P. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor α and risk of Alzheimer's disease and vascular dementia a case-control study. Lancet. 357:2001;436
20. Papassotiropoulos A., Hock C., Nitsch R.M. Genetics of interleukin 6 implications for Alzheimer's disease. Neurobiol Aging. 22:2001;863
21. Pola R., Flex A., Gaetani E., Dal Lago A., Gerardino L., Pola P., Bernabei R. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population. Neuroreport. 13:2002;1645
22. Bruunsgaard H., Andersen-Ranberg K., Jeune B., Pedersen A.N., Skinhoj P., Pedersen B.K. A high plasma concentration of TNF-α is associated with dementia in centenarians. J Gerontol Med Sci. 54a:1999;M357
23. Paganelli R., Di Iorio A., Patricelli L., Ripani F., Sparvieri E., Faricelli R., Iarlori C., Porreca E., Di Gioacchino M., Abate G. Proinflammatory cytokines in sera of elderly patients with dementia levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients. Exp Gerontol. 37:2002;257
24. Hull J., Thomson A., Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax. 55:2000;1023
25. Miller R.J., Meucci O. AIDS and the brain is there a chemokine connection? TINS. 22:1999;471
26. Mackay C.R. Chemokines immunology's high impact factors. Nat Immunol. 2:2001;95
27. Skipper L., Farrer M. Parkinson's genetics molecular insights for the new millennium. Neurotoxicology. 23:2002;503
28. Lui B., Gao H.M., Wang J.Y., Jeohn G.H., Cooper C.L., Hong J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann N Y Acad Sci. 962:2002;318
29. Soliman M.K., Mazzio E., Soliman K.F.A. Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells. Life Sci. 72:2002;185
30. John S., Turner D., Donn R., Sinnott P., Worthington J., Ollier W.E., Hutchinson I.V., Hajeer A.H. Two novel bialleic polymorphisms in the IL-2 gene. Eur J Immunogenet. 25:1998;419
31. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 102:1998;1369
32. Barber M.D., Powell J.J., Lynch S.F., Gough N.J., Fearon K.C., Ross J.A. Two polymorphisms of the tumour necrosis factor gene do not influence survival in pancreatic cancer. Clin Exp Immunol. 117:1999;425